Loading the security overview…
Where the tokens are
What United Therapeutics has filed with the US Securities and Exchange Commission: annual and quarterly reports, current reports of material events, and the forms insiders file when they trade. Each links to the filing’s page on SEC.gov.
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Sep 8, 2026 | 8-K | Current report | On SEC.gov |
| Aug 5, 2026 | 8-K | Current report | On SEC.gov |
| Aug 5, 2026 | 10-Q | Quarterly report | On SEC.gov |
| Jul 23, 2026 | 8-K | Current report | On SEC.gov |
| Jun 29, 2026 | 8-K | Current report | On SEC.gov |
| May 6, 2026 | 8-K | Current report | On SEC.gov |
| May 6, 2026 | 10-Q | Quarterly report | On SEC.gov |
| Mar 30, 2026 | 8-K | Current report | On SEC.gov |
| Mar 9, 2026 | 8-K | Current report | On SEC.gov |
| Mar 2, 2026 | 8-K | Current report | On SEC.gov |
| Feb 25, 2026 | 8-K | Current report | On SEC.gov |
| Feb 25, 2026 | 10-K | Annual report | On SEC.gov |
| Jan 22, 2026 | 8-K | Current report | On SEC.gov |
| Oct 29, 2025 | 8-K | Current report | On SEC.gov |
| Oct 29, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Sep 2, 2025 | 8-K | Current report | On SEC.gov |
| Aug 1, 2025 | 8-K | Current report | On SEC.gov |
| Jul 30, 2025 | 8-K | Current report | On SEC.gov |
| Jul 30, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Jun 27, 2025 | 8-K | Current report | On SEC.gov |
| Apr 30, 2025 | 8-K | Current report | On SEC.gov |
| Apr 30, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Apr 28, 2025 | 8-K | Current report | On SEC.gov |
| Feb 26, 2025 | 8-K | Current report | On SEC.gov |
| Feb 26, 2025 | 10-K | Annual report | On SEC.gov |
| Jan 13, 2025 | 8-K | Current report | On SEC.gov |
| Oct 30, 2024 | 8-K | Current report | On SEC.gov |
| Oct 30, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Jul 31, 2024 | 8-K | Current report | On SEC.gov |
| Jul 31, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Jun 27, 2024 | 8-K | Current report | On SEC.gov |
| May 1, 2024 | 8-K | Current report | On SEC.gov |
| May 1, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Mar 29, 2024 | 8-K | Current report | On SEC.gov |
| Mar 25, 2024 | 8-K | Current report | On SEC.gov |
| Feb 27, 2024 | 8-K | Current report | On SEC.gov |
| Feb 21, 2024 | 8-K | Current report | On SEC.gov |
| Feb 21, 2024 | 10-K | Annual report | On SEC.gov |
| Dec 20, 2023 | 8-K | Current report | On SEC.gov |
| Nov 29, 2023 | 8-K | Current report | On SEC.gov |
| Nov 1, 2023 | 8-K | Current report | On SEC.gov |
| Nov 1, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Aug 2, 2023 | 8-K | Current report | On SEC.gov |
| Aug 2, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Jul 24, 2023 | 8-K | Current report | On SEC.gov |
| Jun 28, 2023 | 8-K | Current report | On SEC.gov |
| May 3, 2023 | 8-K | Current report | On SEC.gov |
| May 3, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Apr 21, 2023 | 8-K | Current report | On SEC.gov |
| Mar 31, 2023 | 8-K | Current report | On SEC.gov |
| Feb 22, 2023 | 8-K | Current report | On SEC.gov |
| Feb 22, 2023 | 10-K | Annual report | On SEC.gov |
| Jan 9, 2023 | 8-K | Current report | On SEC.gov |
| Nov 2, 2022 | 8-K | Current report | On SEC.gov |
| Nov 2, 2022 | 10-Q | Quarterly report | On SEC.gov |
| Oct 11, 2022 | 8-K | Current report | On SEC.gov |
| Sep 20, 2022 | 8-K | Current report | On SEC.gov |
| Sep 1, 2022 | 8-K | Current report | On SEC.gov |
| Aug 3, 2022 | 8-K | Current report | On SEC.gov |
| Aug 3, 2022 | 10-Q | Quarterly report | On SEC.gov |
Figures describe United Therapeutics shares, not any token. As of Oct 1, 2026, from EDGAR, via Massive. Token issuers file nothing here about the company; their own disclosures are on their issuer pages.